Anavex Life Sciences Receives FDA Feedback on Alzheimer’s Disease Program

Go back to Anavex Life Sciences Receives FDA Feedback on Alzheimer’s Disease Program
Anavex Life Sciences Corp. (NASDAQ: AVXL) Delayed: 1.82 --0 (-0%)
Previous Close $1.82    52 Week High $8.30 
Open $1.82    52 Week Low $2.43 
Day High $1.82    P/E N/A 
Day Low $1.82    EPS $-0.22 
Volume 226       

Anavex Life Sciences Corp. (NASDAQ: AVXL) Delayed: 1.82 --0 (-0%)
Previous Close $1.82    52 Week High $8.30 
Open $1.82    52 Week Low $2.43 
Day High $1.82    P/E N/A 
Day Low $1.82    EPS $-0.22 
Volume 226